Is this company worth looking into?

Discussion in 'Grifols USA' started by Anonymous, Aug 26, 2014 at 5:34 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Gamunex-C is fighting an uphill battle. The SPs don't like branded scripts because our margin is poor - the subq market is dominated by Baxter and CSL. Several upperlevel jackwads left to go to BPL - if you are in need of a paycheck - come on over but there is nothing special here
     

  2. Anonymous

    Anonymous Guest

    Prior poster is 100% accurate. Gamunex-C is the lowest margin product for the specialty pharmacies. They are not going to assist in getting scripts. They are paid on revenue.